VALO OPAL COMPUTATIONAL PLATFORM

Dead / Abandoned — Abandoned — failure to respond (as of 29 Jul 2024)

What this means for you

This application is over — abandoned 08 Jul 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
90181491
Mark type
Stylized text
Filed
15 Sept 2020
Abandoned
08 Jul 2024
Attorney of record
Allison Strickland Ricketts

Goods and services

  • Class 009 — Scientific and electric apparatus: downloadable and recorded software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; downloadable and recorded software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement
  • Class 042 — Scientific and technological services: Research and development in the field of drug discovery and development, computational biology, bioinformatics, and genomics; technical scientific consultation and product development for others in the fields of drug discovery and development, pharmaceuticals, biotechnology and immunology; software as a service for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement; consulting in the fields of drug discovery and development, clinical trial management and patient engagement in drug clinical trials

Owner

Prosecution history

  • 29 Jul 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
  • 29 Jul 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
  • 12 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 12 Jun 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 12 Jun 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 28 Mar 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
  • 28 Mar 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
  • 06 Jan 2024 — NOTIFICATION OF SUBSEQUENT FINAL EMAILED
  • 06 Jan 2024 — SUBSEQUENT FINAL EMAILED
  • 06 Jan 2024 — SUBSEQUENT FINAL REFUSAL WRITTEN
  • 14 Dec 2023 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
  • 24 Mar 2023 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
  • 24 Mar 2023 — LETTER OF SUSPENSION E-MAILED
  • 24 Mar 2023 — SUSPENSION LETTER WRITTEN
  • 23 Feb 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED

View this trademark record on Marksy